CDC studies look at COVID-19 vaccine booster effectiveness, safety
During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released Friday by the Centers for Disease Control and Prevention. A third dose was more effective than a second dose but less effective over time, the study found.
In a separate study reported Friday, adverse reactions were less frequent after a third dose than a second dose in adults who received the same COVID-19 vaccine for all their doses.
Related News Articles
Headline
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…
Headline
The Food and Drug Administration authorized for marketing the first at-home over-the-counter test for COVID-19 using a traditional premarket review…
Headline
New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had…
Headline
The Centers for Medicare & Medicaid Services May 31 released regulatory changes to the COVID-19 health care staff vaccination requirements and long-term…
#HealthCareInnovation Blog
In the fall of 2021, two years into the COVID-19 pandemic in the U.S., nearly 80% of adults said they had heard “at least one of eight different false…
Headline
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-…